MedTrace Logo

Validation of Predictors of OAC Initiation Using EMR Data

NCT03006341 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 140187

Last updated 2019-03-22

Study results available
· View outcomes & findings →

Summary

The objectives of this study are, first, to identify select clinical covariates from electronic medical records (EMR) that might be associated with initiation of oral anticoagulant medications (dabigatran or warfarin) in patients with non-valvular atrial fibrillation (NVAF) at risk for stroke; second, to quantify the association between EMR-based clinical characteristics and patterns of insurance claims; third, to assess the potential for unmeasured confounding in dabigatran vs warfarin comparative effectiveness and safety studies based on administrative claims databases.

Conditions

Interventions

DRUG

Dabigatran etexilate

observed upto 12 months

DRUG

Warfarin

Observed upto 12 months

Sponsors & Collaborators

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-02-28
Primary Completion
2017-05-09
Completion
2017-05-09
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03006341 on ClinicalTrials.gov